POTENTIAL CONFLICT OF INTEREST: Dr Pollack reports stock ownership in Gilead Pharmaceuticals. The work detailed here does not evaluate any specific drug or intervention produced by Gilead. In September 2019, Johns Hopkins University entered into a contract with the Department of Housing and Urban Development for Dr Pollack to work part-time on a temporary assignment, assisting the department on housing and health issues. The findings and conclusions in this article are those of the authors and do not necessarily represent those of Housing and Urban Development or other government agencies. Dr Pollack was previously on the Health Advisory Council for Enterprise Community Partners and was a paid consultant to the Open Communities Alliance. Drs Pollack and Leifheit signed on as amici to several Amicus Curiae briefs in support of the Centers for Disease Control and Prevention’s national moratorium on eviction as a public health measure. Dr Leifheit has provided expert testimony to legislative bodies regarding potential public health effects of eviction. Ms Goplerud has no conflicts of interest to disclose.